Here’s what ChatGPT maker Open AI CEO has to say on taking psychedelic drugs that made 8 tech CEOs quit

Recently, in a viral social media post Austen Allred, the CEO and co-founder of BloomTech claimed that eight Silicon Valley CEOs have resigned from their positions after experimenting with psychedelic drugs. Now, OpenAI CEO, Sam Altman has also revealed that he has been taking psychedelic drugs.